Livzon Pharmaceutical Group logo

Livzon Pharmaceutical Group

Asia, Guangdong, China, Zhuhai

Description

Livzon is a comprehensive pharmaceutical enterprise integrating development & research, production and sales of pharmaceutical products.

Investor Profile

Livzon Pharmaceutical Group has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 25% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Medical, Health Care.

Stage Focus

  • Series B (75%)
  • Series C (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Life Science
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Health Diagnostics
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Livzon Pharmaceutical Group frequently co-invest with?

Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 3
Solasta Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 3
Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
4BIO Capital
Europe, England, United Kingdom, London
Co-Investments: 2
MRL Ventures Fund
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
TPG Biotech
North America, California, United States, San Francisco
Co-Investments: 3
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 3
AbbVie Biotech Ventures
North America, Illinois, United States, North Chicago
Co-Investments: 2
SL
North America, District of Columbia, United States, Washington
Co-Investments: 3
IP Group
Europe, England, United Kingdom, London
Co-Investments: 2

What are some of recent deals done by Livzon Pharmaceutical Group?

Carisma Therapeutics

Philadelphia, Pennsylvania, United States

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series CSep 21, 2022
Amount Raised: $30,000,000
Carisma Therapeutics

Philadelphia, Pennsylvania, United States

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series BMar 1, 2021
Amount Raised: $12,000,000
Carisma Therapeutics

Philadelphia, Pennsylvania, United States

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series BJan 7, 2021
Amount Raised: $47,000,000
LungLife AI

Thousand Oaks, California, United States

LungLife AI is a molecular diagnostics company that involves in the early detection and treatment of cancer.

Artificial Intelligence (AI)BiotechnologyHealth DiagnosticsMachine LearningMedical
Series BJun 17, 2015
Amount Raised: $25,500,000

Find More Investors Like Livzon Pharmaceutical Group

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Livzon Pharmaceutical Group | Pipeseed